期刊文献+

金融发展与医药制造业发展间关系的实证分析——基于我国省级面板数据 被引量:1

Empirical Study on Relationship between Financial Development and Pharmaceutical Industry Development:Based on Provincial Panel Data of China
下载PDF
导出
摘要 利用1995—2008年我国29个省级地区的面板数据,利用面板数据的固定效应变截距模型和固定效应变系数模型,对金融发展与医药制造业发展之间的关系进行了实证分析。研究结果表明:我国金融发展对医药制造业发展的影响具有显著的地区差异;在西部地区,前者对后者具有显著的积极影响;在东部地区,前者对后者具有正面影响,但统计上不显著;在中部地区,前者对后者具有负面影响,但统计上不显著。最后提出应充分发挥政策性金融在医药制造业发展中的作用。 Using the panel data of 29 provinces of China from 1995 to 2008,this paper empirically studies the relationship between financial development and pharmaceutical industry development by the variable intercept panel data model with fixed effect and the variable coefficient panel data model with fixed effect.The results show as follows:there exists the significant regional difference in the impact of financial development on pharmaceutical industry in China;financial development in western region has a significant positive impact on pharmaceutical industry;in eastern region,the impact of the former on the latter is positive,but is not statistically significant;in central region,the impact of the former on the latter is negative,but is not statistically significant.Finally,it proposes that the effect of policy finance should be paid fully.
机构地区 江南大学商学院
出处 《技术经济》 CSSCI 2012年第4期45-51,共7页 Journal of Technology Economics
基金 教育部人文社会科学研究规划基金项目"供应链模式与价格传导机制研究"(12YJA630007) 中央高校基本科研业务费专项资金资助项目"网上拍卖:博弈分析与机制设计"(JUSRP211A65)
关键词 医药制造业 金融发展 融资渠道 pharmaceutical industry financial development financial channel
  • 相关文献

参考文献19

  • 1TODD J W.The pharmaceutical industry[J].British Med-ical Journal,1958,10(4):846-849.
  • 2JANSSON S-O,VESSMAN J.Trends in product analysisfor research in the pharmaceutical industry[J].Mikro-chimica Acta,1991,(1):103-112.
  • 3MAHLICH J C,ROEDIGER-SCHLUGA T.The chan-ging nature of pharmaceutical R&D-opportunities for Asia[J].Management of Technological Innovation and R&D,2001(3):1-9.
  • 4GIULIO BOTTAZZI,ANGELO SECCHI.Growth andDiversification Patterns of the Worldwide PharmaceuticalIndustry[J].Review of Industrial Organization,2005,3(2):195-216.
  • 5GRILICHES Z,COCKBURN I.Generics and new goods inpharmaceutical price indexes[J].American Economic Re-view,1994,5(84):1213-1232.
  • 6ALEXANDER D L,FLYNN J E,LINKINS L A.Innova-tion,R&D productivity,and global market share in thepharmaceutical industry[J].Review of Industrial Organi-zation,1995(2):197-207.
  • 7ACEMOGLU D,LINN J.Market size in innovation:theo-ry and evidence from the pharmaceutical industry[J].Quarterly Journal of Economics,2004,8(3):1049-1090.
  • 8GEIJO F.Quality management in analytical R&D in thepharmaceutical industry:building quality from GLP[J].Accreditation and Quality Assurance,2000(1):16-20.
  • 9NAIR M D.TRIPS,WTO and IPR:impact of Indian Pa-tent Act 2005on Indian pharmaceutical industry[J].Jour-nal of Intellectual Property Rights,2010,15(6):474-476.
  • 10顾海,卫陈.中国医药产业集中度实证研究[J].南京社会科学,2006(11):34-39. 被引量:26

二级参考文献86

共引文献198

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部